Business Context and Reporting Period
Company: Minerva Neurosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 27, 2015
Event: Entry into a Material Definitive Agreement involving a First Amendment to an existing Loan and Security Agreement.
Key Financial Metrics
This filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, or total debt levels. The document focuses exclusively on the amendment of a credit facility.
Material Changes
- Agreement Amendment: On August 27, 2015, the Company entered into a First Amendment to its Loan and Security Agreement dated January 16, 2015.
- Counterparties: The amendment was executed with Oxford Finance LLC and Silicon Valley Bank (collectively, the "Lenders").
- Reference: The original Loan Agreement was previously filed as Exhibit 10.1 to the Company's Form 8-K dated January 20, 2015.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details regarding unusual items. The document serves strictly to disclose the execution of the loan amendment.
Investor Verification Checklist
- Review the full text of the First Amendment to Loan and Security Agreement (Exhibit 10.1) to understand specific changes to interest rates, covenants, maturity dates, or principal amounts.
- Compare the amended terms against the original Loan and Security Agreement filed on January 20, 2015.
- Verify the Company's current liquidity position in the most recent quarterly or annual report (10-Q or 10-K) to assess the impact of this debt facility.